ser7

KB-0742 dihydrochloride 是一种有效的、选择性的、口服的 CDK9 抑制剂，具有抗肿瘤活性，对CDK9/cyclin T1的IC50为 6 nM。它对CDK9/cyclin T1具有选择性，其选择性是其他 CDK 激酶的 50 倍以上。

[pSer2, pSer5, pSer7]-CTD (TFA) is a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD) and a substrate for CDK7 (cyclin-dependent protein kinase).

[pSer2, pSer5, pSer7]-CTD is a substrate for CDK7(cyclin-dependent protein kinase), a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD).

Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tu

CCK1-specific peptide substrate 是一种具有生物活性的肽。(该肽的序列基于 Ser7 磷酸化的兔肌糖原合酶。它是酪蛋白激酶 I (CK1) 的肽底物。CK1 作用于 Ser10 的磷酸化。Ser7 在体内被 PKA 磷酸化。)